Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

The updated SALT II tool offers a more precise way to measure scalp hair loss.

Alopecia areata affects quality of life more in adolescents than adults.

More severe hair loss links to thicker heart fat, suggesting possible heart disease risk.

Hair loss may indicate higher risk of heart disease.

Higher antigliadin antibody levels are linked to alopecia areata severity.

More severe alopecia areata can lower quality of life.

Lower BDNF levels link to worse depression in alopecia areata patients.

Current treatments for Alopecia Areata don't fully meet patients' needs, indicating a need for better therapies.

Hair loss doesn't affect COVID-19 severity.

Severe COVID-19 often leads to hair loss in India.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

miR-155-5p can help diagnose and track alopecia areata severity.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Alopecia areata seriously lowers quality of life, especially affecting self-image, mental health, and social life.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

The model accurately predicts hair loss severity in alopecia areata.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

Baricitinib is effective and safe for treating severe alopecia areata.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

Scoring systems help doctors assess and treat skin diseases effectively.

Combining calcipotriol and PRP is most effective for treating Alopecia Areata.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

New tools help doctors better assess and treat alopecia areata in kids by considering more than just hair loss.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Intralesional steroids improve Alopecia Areata, and trichoscopy effectively tracks this improvement.